| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Josamycin | Josamycin EP Impurity A | VE009123 | View CAS 18361-46-1 |
Josamycin Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Josamycin | Josamycin EP Impurity A | VE009123 | View CAS 18361-46-1 |
| Catalogue No. | VE009123 |
| CAS No. | 18361-46-1 |
| Molecular Formula | C41H67NO15 |
| Molecular Weight | 813.98 g/mol |
| Parent drug | Josamycin |
| IUPAC Name | (4R, 5S, 6S, 7R, 9R, 10R, 11E, 13E, 16R)-4-(Acetyloxy)-6-[[3, 6-dideoxy-4-O-(2, 6-dideoxy-4-O-butanoyl-3-C-methyl-α-L-ribo-hexopyranosyl)-3-(dimethylamino)-β-D-glucopyranosyl]oxy]-10-hydroxy-5-methoxy-9, 16-dimethyl-7-(2-oxoethyl)oxacyclohexadeca-11, 13-dien-2-one |
| Synonyms | Leukomycin A4 |
| References | Sci-Hub, Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin. BMC Infectious Diseases, 15(1), 10.1186/s12879-015-0781-7. (2015). Retrieved June 13, 2022, from Sci-hub.se website: https://sci-hub.se/https://doi.org/10.1186/s12879-015-0781-7 |
| Status | In-stock |
| ListName | Josamycin EP Impurity A |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
